Clinical Trial Update: Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating upfront plerixafor in autologous transplantation and its clinical and economic impact in Non-Hodgkin's Lymphoma and Mul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: University of Florida | Conditions: Non-Hodgkin's Lymphoma, Multiple Myeloma | Phase 2 | Status: COMPLETED